Lucia Esposito

Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With <i>RAS</i> Wild-type Metastatic Colorectal Cancer

Erika Martinelli, Giulia Martini, Vincenzo Famiglietti et al. · JAMA Oncology · 2021 · 185 citations · Full text

Medicine, Oncology, Pharmacology +17

Gut microbiota correlates with antitumor activity in patients with <scp>mCRC</scp> and <scp>NSCLC</scp> treated with cetuximab plus avelumab

Giulia Martini, Davide Ciardiello, Marcello Dallio et al. · International Journal of Cancer · 2022 · 66 citations · Full text

Life Sciences, Microbiology, Oncology +17

Panitumumab Plus Trifluridine-Tipiracil as Anti–Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory <i>RAS</i> Wild-Type Metastatic Colorectal Cancer

Stefania Napolitano, Vincenzo De Falco, Giulia Martini et al. · JAMA Oncology · 2023 · 58 citations · Full text

Medicine, Oncology, Pharmacology +17

Panitumumab plus trifluridine/tipiracil as anti‐<scp>EGFR</scp> rechallenge therapy in patients with refractory <scp><i>RAS</i></scp> wild‐type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase <scp>II VELO</scp> trial

Stefania Napolitano, Davide Ciardiello, Vincenzo De Falco et al. · International Journal of Cancer · 2023 · 40 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids

Damiano D’Ardes, Michela Pontolillo, Lucia Esposito et al. · Microorganisms · 2020 · 26 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +11